Probiotec Limited (DE:PG3)
BERLIN:PG3
Holding DE:PG3?
Track your performance easily

Probiotec Limited (PG3) Financial Statements

0 Followers

Probiotec Limited Financial Overview

Probiotec Limited's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Probiotec Limited is scheduled to report earnings on August 21, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 22.20MAU$ 28.43MAU$ 6.31MAU$ 8.84MAU$ 1.82M
Total AssetsAU$ 237.91MAU$ 230.88MAU$ 134.06MAU$ 106.37MAU$ 93.66M
Total DebtAU$ 92.99MAU$ 97.29MAU$ 38.02MAU$ 30.72MAU$ 14.92M
Net DebtAU$ 70.79MAU$ 68.87MAU$ 31.72MAU$ 21.87MAU$ 13.11M
Total LiabilitiesAU$ 158.86MAU$ 162.26MAU$ 73.55MAU$ 56.52MAU$ 41.31M
Stockholders EquityAU$ 79.05MAU$ 68.61MAU$ 60.51MAU$ 49.85MAU$ 52.35M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Probiotec Limited Earnings and Revenue History

Probiotec Limited Debt to Assets

Probiotec Limited Cash Flow

Probiotec Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis